These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15251129)

  • 1. The role of the CD40 pathway in the pathogenesis and treatment of cancer.
    Eliopoulos AG; Young LS
    Curr Opin Pharmacol; 2004 Aug; 4(4):360-7. PubMed ID: 15251129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for CD40-directed experimental therapy of human cancer.
    Tong AW; Stone MJ
    Cancer Gene Ther; 2003 Jan; 10(1):1-13. PubMed ID: 12489023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospect of targeting the CD40 pathway for cancer therapy.
    Vonderheide RH
    Clin Cancer Res; 2007 Feb; 13(4):1083-8. PubMed ID: 17317815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth.
    Baxendale AJ; Dawson CW; Stewart SE; Mudaliar V; Reynolds G; Gordon J; Murray PG; Young LS; Eliopoulos AG
    Oncogene; 2005 Nov; 24(53):7913-23. PubMed ID: 16091748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas.
    Vardouli L; Lindqvist C; Vlahou K; Loskog AS; Eliopoulos AG
    Cancer Gene Ther; 2009 Nov; 16(11):848-60. PubMed ID: 19461675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Janus faces of CD40 in cancer.
    Loskog AS; Eliopoulos AG
    Semin Immunol; 2009 Oct; 21(5):301-7. PubMed ID: 19647448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model.
    Hunter TB; Alsarraj M; Gladue RP; Bedian V; Antonia SJ
    Scand J Immunol; 2007 May; 65(5):479-86. PubMed ID: 17444959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation.
    Luczyński W; Kowalczuk O; Iłendo E; Stasiak-Barmuta A; Krawczuk-Rybak M
    Ann Hematol; 2007 May; 86(5):339-45. PubMed ID: 17285277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 ligation converts TGF-beta-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic ones.
    Zhang X; Kedl RM; Xiang J
    Biochem Biophys Res Commun; 2009 Feb; 379(4):954-8. PubMed ID: 19135981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor regression by anti-CD40 and interleukin-2: role of CD40 in hematopoietic cells and organ-specific effects.
    Welniak LA; Shorts L; Subleski J; Blazar BR; Wiltrout RH; Murphy WJ
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):534-9. PubMed ID: 15282531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo.
    Wu Y; Wang L; He X; Xu H; Zhou L; Zhao F; Zhang Y
    Cell Immunol; 2008; 253(1-2):102-9. PubMed ID: 18603231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40: a growing cytoplasmic tale.
    Harnett MM
    Sci STKE; 2004 Jun; 2004(237):pe25. PubMed ID: 15199223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
    Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
    Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 promotion of amyloid beta production occurs via the NF-kappaB pathway.
    Ait-Ghezala G; Volmar CH; Frieling J; Paris D; Tweed M; Bakshi P; Mullan M
    Eur J Neurosci; 2007 Mar; 25(6):1685-95. PubMed ID: 17432959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling.
    Wieckowski S; Trouche N; Chaloin O; Guichard G; Fournel S; Hoebeke J
    Biochemistry; 2007 Mar; 46(11):3482-93. PubMed ID: 17319699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
    Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outside inside signalling in CD40-mediated B cell activation.
    D'Orlando O; Gri G; Cattaruzzi G; Merluzzi S; Betto E; Gattei V; Pucillo C
    J Biol Regul Homeost Agents; 2007; 21(3-4):49-62. PubMed ID: 18261257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
    Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
    Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.